We are live on ! Find out more
CAM

Concorde Asset Management Portfolio holdings

AUM $204M
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$168M
AUM Growth
-$5.71M
Cap. Flow
-$16.7M
Cap. Flow %
-9.98%
Top 10 Hldgs %
26.25%
Holding
208
New
14
Increased
71
Reduced
72
Closed
40

Top Sells

Rank Stock Value
1
TEAM icon
Atlassian
TEAM
+$2.55M
2
AGNC icon
AGNC Investment
AGNC
+$1.77M
3
T icon
AT&T
T
+$1.56M
4
APTS
Preferred Apartment Communities, Inc.
APTS
+$1.54M
5
ZS icon
Zscaler
ZS
+$1.34M

Sector Composition

Rank Sector Weight
1 Technology 9.3%
2 Real Estate 8.99%
3 Financials 6.2%
4 Consumer Staples 4.9%
5 Healthcare 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLX icon
151
Clorox
CLX
$11.6B
$216K 0.13%
1,238
-260
-17% -$43.3K
ABBV icon
152
AbbVie
ABBV
$443B
$214K 0.13%
1,554
-1,104
-42% -$130K
ABT icon
153
Abbott
ABT
$183B
$214K 0.13%
+1,561
New +$200K
IJK icon
154
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.7B
$214K 0.13%
+2,511
New +$211K
DE icon
155
Deere & Co
DE
$160B
$212K 0.13%
619
HON icon
156
Honeywell
HON
$77B
$212K 0.13%
1,080
+2
+0.2% +$404
UPS icon
157
United Parcel Service
UPS
$88.6B
$208K 0.12%
+970
New +$197K
CAT icon
158
Caterpillar
CAT
$375B
$207K 0.12%
+1,000
New +$201K
RPRX icon
159
Royalty Pharma
RPRX
$25.9B
$206K 0.12%
5,168
-5,442
-51% -$211K
HYZN
160
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$189K 0.11%
582
+202
+53% +$65.8K
RITM icon
161
Rithm Capital
RITM
$5.52B
$181K 0.11%
16,872
+300
+2% +$3.35K
DNA icon
162
Ginkgo Bioworks
DNA
$528M
$167K 0.1%
504
+35
+7% +$16.6K
KMI icon
163
Kinder Morgan
KMI
$71.7B
$167K 0.1%
10,500
-192
-2% -$3.19K
NXDT
164
NexPoint Diversified Real Estate Trust
NXDT
$234M
$150K 0.09%
+11,050
New +$156K
NRO
165
Neuberger Real Estate Securities Income Fund Inc
NRO
$191M
$74K 0.04%
14,672
SQQQ icon
166
ProShares UltraPro Short QQQ
SQQQ
$2.04B
$67K 0.04%
+90
New +$76.3K
NBEV
167
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$56K 0.03%
54,500
ANIX icon
168
Anixa Biosciences
ANIX
$116M
$48K 0.03%
16,000
+3,000
+23% +$12.1K
ADBE icon
169
Adobe
ADBE
$99.5B
-552
Closed -$318K
AGNC icon
170
AGNC Investment
AGNC
$12.4B
-112,129
Closed -$1.77M
APPN icon
171
Appian
APPN
$1.98B
-5,967
Closed -$552K
ARKG icon
172
ARK Genomic Revolution ETF
ARKG
$1.55B
-2,745
Closed -$205K
BSY icon
173
Bentley Systems
BSY
$10.8B
-8,067
Closed -$489K
CRSP icon
174
CRISPR Therapeutics
CRSP
$4.73B
-4,782
Closed -$535K
CVX icon
175
Chevron
CVX
$392B
-2,485
Closed -$252K

Similar funds

Concorde Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Concorde Asset Management held 208 positions worth $168M, down 3.3% from $173M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Concorde Asset Management withdrew a net $16.7M in Q4 2021, closing 40 positions and reducing 72 holdings. Its most notable exit was Atlassian, an estimated $2.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 14% a quarter earlier, followed by Real Estate and Financials.

Against the trend, Concorde Asset Management opened a new position in Alignment Healthcare worth $964K.

  • Concorde Asset Management's largest Q4 2021 buy was Alignment Healthcare: 68,580 shares worth $964K.
  • Concorde Asset Management added most to British American Tobacco in Q4 2021, an estimated $1.28M increase.
  • Concorde Asset Management's biggest Q4 2021 reduction was Zscaler, cutting an estimated $1.34M.
  • Concorde Asset Management fully exited Atlassian in Q4 2021, selling an estimated $2.55M.
  • Concorde Asset Management's ten largest holdings make up 26% of its $168M portfolio in Q4 2021.
  • Concorde Asset Management opened 14 new positions and closed 40 in Q4 2021.
  • Concorde Asset Management's portfolio value fell 3.3% quarter-over-quarter to $168M.

Based on Concorde Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.